Glycogen synthase kinase 3 in Wnt signaling pathway and cancer

IUBMB Life

Volumn 67, Issue 12, 2015, Pages 914-922

  Tejeda Muñoz, Nydia ^a   Robles Flores, Martha ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

colon cancer; GSK 3; GSK 3 regulation; Wnt signaling

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA; GUANOSINE TRIPHOSPHATASE; PROTEIN KINASE; S6 KINASE; WNT PROTEIN; ISOENZYME; PROTEIN KINASE INHIBITOR;

CANCER GROWTH; CELLULAR DISTRIBUTION; COLON CANCER; MALIGNANT TRANSFORMATION; NEOPLASM; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; WNT SIGNALING PATHWAY; ANIMAL; ANTAGONISTS AND INHIBITORS; COLONIC NEOPLASMS; GENETICS; HUMAN; METABOLISM; MOLECULARLY TARGETED THERAPY; NEOPLASMS;

ANIMALS; COLONIC NEOPLASMS; GLYCOGEN SYNTHASE KINASE 3; HUMANS; ISOENZYMES; MOLECULAR TARGETED THERAPY; NEOPLASMS; PROTEIN KINASE INHIBITORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84951852496     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.1454     Document Type: Review

References (71)

1. Embi, N., Rylatt, D. B., and, Cohen, P, (1980) Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase. Eur. J. Biochem. 107, 519-527
2. Jope, R. S., and, Johnson, G. V., (2004) The glamour and gloom of glycogen synthase kinase-3. Trends Biochem. Sci. 29, 95-102.
3. Frame, S., and, Cohen, P., (2001) GSK3 takes centre stage more than 20 years after its discovery. Biochem. J. 359, 1-16.
4. Grimes, C. A., and, Jope, R. S., (2001) The multifaceted roles of glycogen synthase kinase 3β in cellular signaling. Prog. Neurobiol. 65, 391-426.
5. Takahashi-Yanaga, F., (2013) Activator or inhibitor? GSK-3 as a new drug target. Biochem. Pharmacol. 86, 191-199.
6. Goto, H., Kawano, K., Kobayashi, I., Sakai, H., and, Yanagisawa, S., (2002) Expression of cyclin D1 and GSK-3β and their predictive value of prognosis in squamous cell carcinomas of the tongue. Oral Oncol. 38, 549-556.
7. Boissan, M., Beurel, E., Wendum, D., Rey, C., Lécluse, Y., et al., (2005) Overexpression of insulin receptor substrate-2 in human and murine hepatocellular carcinoma. Am. J. Pathol. 167, 869-877.
8. Ban, K. C., Singh, H., Krishnan, R., and, Seow, H. F., (2003) GSK-3β phosphorylation and alteration of β-catenin in hepatocellular carcinoma. Cancer Lett. 199, 201-208.
9. MacAulay, K., Doble, B. W., Patel, S., Hansotia, T., Sinclair, E. M., et al., (2007) Glycogen synthase kinase 3α-specific regulation of murine hepatic glycogen metabolism. Cell Metab. 6, 329-337.
10. Lustig, B., and, Behrens, J., (2003) The Wnt signaling pathway and its role in tumor development. J. Cancer Res. Clin. Oncol. 129, 199-221.
11. Jeong, W. J., Yoon, J., Park, J. C., Lee, S. H., Lee, S. H., et al., (2012) Ras stabilization through aberrant activation of Wnt/β-catenin signaling promotes intestinal tumorigenesis. Sci. Signal. 5, ra30.
12. McCubrey, J. A., Steelman, L. S., Bertrand, F. E., Davis, N. M., Sokolosky, M., et al., (2014) GSK-3 as potential target for therapeutic intervention in cancer. Oncotarget 5, 2881-2911.
13. Bilim, V., Ougolkov, A., Yuuki, K., Naito, S., Kawazoe, H., et al., (2009) Glycogen synthase kinase-3: a new therapeutic target in renal cell carcinoma. Br. J. Cancer 101: 2005-2014.
14. Woodgett, J. R., (1990) Molecular cloning and expression of glycogen synthase kinase-3/factor A. EMBO J. 9, 2431-2438.
15. Lau, K. F., Miller, C. C., Anderton, B. H., and, Shaw, P. C., (1999) Expression analysis of glycogen synthase kinase-3 in human tissues. J. Pept. Res. 54, 85-91.
16. Yao, H. B., Shaw, P. C., Wong, C. C., and, Wan, D. C., (2002) Expression of glycogen synthase kinase-3 isoforms in mouse tissues and their transcription in the brain. J. Chem. Neuroanat. 23, 291-297.
17. Shaw, P. C., Davies, A. F., Lau, K. F., Garcia-Barcelo, M., Waye, M. M., et al., (1998) Isolation and chromosomal mapping of human glycogen synthase kinase-3α and -3β encoding genes. Genome 41, 720-727.
18. Ali, A., Hoeflich, K. P., and, Woodgett, J. R., (2001) Glycogen synthase kinase-3: properties, functions and regulation. Chem. Rev. 101, 2527-2540.
19. Hoeflich, K. P., Luo, J., Rubie, E. A., Tsao, M. S., Jin, O., et al., (2000) Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation. Nature 406, 86-90.
20. Wang, Y., Hou, Y., Zhao, L., He, Z., Jiang, J., et al., (2014) Multiple alternative splicing and differential expression pattern of the glycogen synthase kinase-3β (GSK3β) gene in goat (Capra hircus). PLoS ONE 9, e109555.
21. Boyle, W. J., Smeal, T., Defize, L. H., Angel, P., Woodgett, J. R., et al., (1991) Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity. Cell 64, 573-584.
22. Hoshi, M., Takashima, A., Noguchi, K., Murayama, M., Sato, M., et al., (1996) Regulation of mitochondrial pyruvate dehydrogenase activity by tau protein kinase I/glycogen synthase kinase 3β in brain. Proc. Natl. Acad. Sci. USA 93, 2719-2723.
23. Bijur, G. N., and, Jope, R. S., (2003) Glycogen synthase kinase-3β is highly activated in nuclei and mitochondria. Neuroreport 14, 2415-2419.
24. Diehl, J. A., Cheng, M., Roussel, M. F., and, Sherr, C. J., (1998) Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 12, 3499-3511.
25. Caspi, M., Zilberberg, A., Eldar-Finkelman, H., and, Rosin-Arbesfeld, R., (2008) Nuclear GSK-3β inhibits the canonical Wnt signalling pathway in a β-catenin phosphorylation-independent manner. Oncogene 27, 3546-3555.
26. Bhat, R. V., Shanley, J., Correll, M. P., Fieles, W. E., Keith, R. A., et al., (2000) Regulation and localization of tyrosine 216 phosphorylation of glycogen synthase kinase-3β in cellular and animal models of neuronal degeneration. Proc. Natl. Acad. Sci. USA 97, 11074-11079.
27. Franca-Koh, J., Yeo, M., Fraser, E., Young, N., and, Dale, T. C., (2002) The regulation of glycogen synthase kinase-3 nuclear export by Frat/GBP. J. Biol. Chem. 277, 43844-43848.
28. Kaidanovich-Beilin, O., and, Woodgett, J. R., (2011) GSK-3: functional insights from cell biology and animal models. Front. Mol. Neurosci. 16, 40.
29. Bax, B., Carter, P. S., Lewis, C., Guy, A. R., Bridges, A., et al., (2001) The structure of phosphorylated GSK-3β complexed with a peptide, FRATtide, that inhibits β-catenin phosphorylation. Structure 9, 1143-1152.
30. Dajani, R., Fraser, E., Roe, S. M., Young, N., Good, V., et al., (2001) Crystal structure of glycogen synthase kinase 3β: structural basis for phosphate-primed substrate specificity and autoinhibition. Cell 105, 721-732.
31. Delcommenne, M., Tan, C., Gray, V., Rue, L., Woodgett, J., et al., (1998) Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Proc. Natl. Acad. Sci. USA 95, 11211-11216.
32. van Weeren, P. C., de Bruyn, K. M., de Vries-Smits, A. M., van Lint, J., and, Burgering, B. M., (1998) Essential role for protein kinase B (PKB) in insulin-induced glycogen synthase kinase 3 inactivation. Characterization of dominant-negative mutant of PKB. J. Biol. Chem. 273, 13150-13156.
33. Quevedo, C., Alcazar, A., and, Salinas, M., (2000) Two different signal transduction pathways are implicated in the regulation of initiation factor 2B activity in insulin-like growth factor-1-stimulated neuronal cells. J. Biol. Chem. 275, 19192-19197.
34. Park, B. C., Kido, Y., and, Accili, D., (1999) Differential signaling of insulin and IGF-1 receptors to glycogen synthesis in murine hepatocytes. Biochemistry 38, 7517-7523.
35. Fang, X., Yu, S. X., Lu, Y., Bast, R. C., Jr., Woodgett, J. R., et al., (2000) Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A. Proc. Natl. Acad. Sci. USA 97, 11960-11965.
36. Beurel, E., Grieco, S. F., and, Jope, R. S., (2015) Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases. Pharmacol. Ther. 148, 114-131.
37. Hughes, K., Nikolakaki, E., Plyte, S. E., Totty, N. F., and, Woodgett, J. R., (1993) Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation. EMBO J. 12, 803-808.
38. Monteserin-Garcia, J., Al-Massadi, O., Seoane, L. M., Alvarez, C. V., Shan, B., et al., (2013) Sirt1 inhibits the transcription factor CREB to regulate pituitary growth hormone synthesis. FASEB J. 27, 1561-1571.
39. Feijs, K. L., Kleine, H., Braczynski, A., Forst, A. H., Herzog, N., et al., (2013) ARTD10 substrate identification on protein microarrays: regulation of GSK3 by mono-ADP-ribosylation. Cell Commun. Signal. 11, 5.
40. Rosenthal, F., Feijs, K. L., Frugier, E., Bonalli, M., Forst, A. H., et al., (2013) Macrodomain-containing proteins are new mono-ADP-ribosylhydrolases. Nat. Struct. Mol. Biol. 20, 502-507.
41. Stadler, S. C., Vincent, C. T., Fedorov, V. D., Patsialou, A., Cherrington, B. D., et al., (2013) Dysregulation of PAD4-mediated citrullination of nuclear GSK3β activates TGF-β signaling and induces epithelial-to-mesenchymal transition in breast cancer cells. Proc. Natl. Acad. Sci. USA 110, 11851-11856.
42. Guo, X., Ramirez, A., Waddell, D. S., Li, Z., Liu, X., et al., (2008) Axin and GSK3- control Smad3 protein stability and modulate TGF-signaling. Genes Dev. 22, 106-120.
43. Mak, B. C., Takemaru, K., Kenerson, H. L., Moon, R. T., and, Yeung, R. S., (2003) The tuberin-hamartin complex negatively regulates β-catenin signaling activity. J. Biol. Chem. 278, 5947-5951.
44. Rosner, M., Hanneder, M., Siegel, N., Valli, A., and, Hengstschläger, M., (2008) The tuberous sclerosis gene products hamartin and tuberin are multifunctional proteins with a wide spectrum of interacting partners. Mutat. Res. 658, 234-246.
45. Doble, B. W., and, Woodgett, J. R., (2003) GSK-3: tricks of the trade for a multitasking kinase. J. Cell Sci. 116, 1175-1186.
46. Agarwal-Mawal, A., Qureshi, H. Y., Cafferty, P. W., Yuan, Z., Han, D., et al., (2003) 14-3-3 connects glycogen synthase kinase-3β to tau within a brain microtubule associated tau phosphorylation complex. J. Biol. Chem. 278, 12722-12728.
47. Liao, W., Wang, S., Han, C., and, Zhang, Y., (2005) 14-3-3 proteins regulate glycogen synthase 3β phosphorylation and inhibit cardiomyocyte hypertrophy. FEBS J. 272, 1845-1854.
48. Schaffer, B., Wiedau-Pazos, M., and, Geschwind, D. H., (2003) Gene structure and alternative splicing of glycogen synthase kinase 3β (GSK-3β) in neural and non-neural tissues. Gene 302, 73-81.
49. Kwok, J. B., Hallupp, M., Loy, C. T., Chan, D. K., Woo, J., et al., (2005) GSK3β polymorphisms alter transcription and splicing in Parkinson's disease. Ann. Neurol. 58, 829-839.
50. Mukai, F., Ishiguro, K., Sano, Y., and, Fujita, S. C., (2002) Alternative splicing isoform of tau protein kinase I/glycogen synthase kinase 3β. J. Neurochem. 81, 1073-1083.
51. Ding, V. W., Chen, R. H., and, McCormick, F., (2000) Differential regulation of glycogen synthase kinase 3β by insulin and Wnt signaling. J. Biol. Chem. 275, 32475-32481.
52. Yuan, H., Mao, J., Li, L., and, Wu, D., (1999) Suppression of glycogen synthase kinase activity is not sufficient for leukemia enhancer factor-1 activation. J. Biol. Chem. 274, 30419-30423.
53. Cselenyi, C. S., Jernigan, K. K., Tahinci, E., Thorne, C. A., Lee, L. A., et al., (2008) LRP6 transduces a canonical Wnt signal independently of Axin degradation by inhibiting GSK3's phosphorylation of β-catenin. Proc. Natl. Acad. Sci. USA 105, 8032-8037.
54. Mi, K., Dolan, P. J., and, Johnson, G. V., (2006) The low density lipoprotein receptor-related protein 6 interacts with glycogen synthase kinase 3 and attenuates activity. J. Biol. Chem. 281, 4787-4794.
55. Piao, S., Lee, S. H., Kim, H., Yum, S., Stamos, J. L., et al., (2008) Direct inhibition of GSK3β by the phosphorylated cytoplasmic domain of LRP6 in Wnt/β-catenin signaling. PLoS ONE 3, e4046.
56. Wu, G., Huang, H., Garcia Abreu, J., and, He, X., (2009) Inhibition of GSK3 phosphorylation of β-catenin via phosphorylated PPPSPXS motifs of Wnt coreceptor LRP6. PLoS ONE 4, e4926.
57. Taelman, V. F., Dobrowolski, R., Plouhinec, J. L., Fuentealba, L. C., Vorwald, P. P., et al., (2010) Wnt signalling requires sequestration of glycogen synthase kinase 3 inside multivesicular endosomes. Cell 143, 1136-1148.
58. Yamamoto, H., Yoo, S. K., Nishita, M., Kikuchi, A., and, Minami, Y., (2007) Wnt5a modulates glycogen synthase kinase 3 to induce phosphorylation of receptor tyrosine kinase Ror2. Genes Cells 12, 1215-1223.
59. Grumolato, L., Liu, G., Mong, P., Mudbhary, R., Biswas, M., et al., (2010) Canonical and noncanonical Wnts use a common mechanism to activate completely unrelated coreceptors. Genes Dev. 24, 2517-2530.
60. Inoki, K., Ouyang, H., Zhu, T., Lindvall, C., Wang, Y., et al., (2006) TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell 126, 955-968.
61. Wu, D., and, Pan, W., (2010) GSK-3: a multifaceted kinase in Wnt signaling. Trends Biochem. Sci. 35, 161-168.
62. Kim, J. S., Piao, S., Lee, E., Yoon, B. Y., Moon, H. R., et al., (2014) Development of Akt activated GSK3β inhibitory peptide. Biochem. Biophys. Res. Commun. 434, 735-739.
63. Leis, H., Segrelles, C., Ruiz, S., Santos, M., and, Paramio, J. M., (2002) Expression, localization, and activity of glycogen synthase kinase 3β during mouse skin tumorigenesis. Mol. Carcinog. 35, 180-185.
64. Ma, C., Wang, J., Gao, Y., Gao, T. W., Chen, G., et al., (2007) The role of glycogen synthase kinase 3β in the transformation of epidermal cells. Cancer Res. 67, 7756-7764.
65. Farago, M., Dominguez, I., Landesman-Bollag, E., Xu, X., Rosner, A., et al., (2005) Kinase-inactive glycogen synthase kinase 3β promotes Wnt signaling and mammary tumorigenesis. Cancer Res. 65, 5792-5801.
66. Armanious, H., Deschenes, J., Gelebart, P., Ghosh, S., Mackey, J., et al., (2010) Clinical and biological significance of GSK-3β inactivation in breast cancer-an immunohistochemical study. Hum. Pathol. 41, 1657-1663.
67. Dembowy, J., Adissu, H. A., Liu, J. C., Zacksenhaus, E., and, Woodgett, J. R., (2015) Effect of glycogen synthase kinase-3 inactivation on mouse mammary gland development and oncogenesis. Oncogene 34, 3514-3526.
68. Shakoori, A., Mai, W., Miyashita, K., Yasumoto, K., Takahashi, Y., et al., (2007) Inhibition of GSK-3β activity attenuates proliferation of human colon cancer cells in rodents. Cancer Sci. 98, 1388-1393.
69. Ougolkov, A. V., Fernandez-Zapico, M. E., Savoy, D. N., Urrutia, R. A., and, Billadeau, D. D., (2005) Glycogen synthase kinase-3β participates in nuclear factor κB mediated gene transcription and cell survival in pancreatic cancer cells. Cancer Res. 65, 2076-2081.
70. Garcea, G., Manson, M. M., Neal, C. P., Pattenden, C. J., Sutton, C. D., et al., (2007) Glycogen synthase kinase-3β; a new target in pancreatic cancer? Curr. Cancer Drug Targets 7, 209-215.
71. Benoit, Y. D., Guezguez, B., Boyd, A. L., and, Bhatia, M., (2014) Molecular pathways: Epigenetic modulation of Wnt-glycogen synthase kinase-3 signaling to target human cancer stem cells. Clin. Cancer Res. 20, 5372-5378.